haloperidol has been researched along with malondialdehyde in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (12.00) | 18.2507 |
| 2000's | 8 (32.00) | 29.6817 |
| 2010's | 11 (44.00) | 24.3611 |
| 2020's | 3 (12.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ravindranath, V; Shivakumar, BR | 2 |
| Gangadhar, BN; Janakiramaiah, N; Pai, BN; Ravindranath, V | 1 |
| Kulkarni, SK; Naidu, PS; Singh, A | 2 |
| Gao, FF; Liu, B; Shi, GG; Zheng, JH | 1 |
| Bishnoi, M; Chopra, K; Kulkarni, SK | 1 |
| Gursoy, B; Kirli, S; Sarandöl, E; Sipahioglu, D; Sivrioglu, EY | 1 |
| Gao, P; Guo, F; Jia, Q; Lv, Y; Shi, G; Tang, Z; Zhang, Y; Zheng, J | 1 |
| Alam, MM; Anwer, T; Azam, F; Barodia, SK | 1 |
| Ahmed, MA; Alkskas, IA; Azam, F | 1 |
| Ciobica, A; Dobrin, I; Padurariu, M; Stefanescu, C | 1 |
| Cai, W; Chen, Y; Gao, F; Guo, F; Shi, G; Wang, J; Zhang, Y; Zheng, J; Zhou, Y | 1 |
| Araújo, FY; Carvalho, AF; Gomes, PX; Macêdo, DS; Oliveira, GV; Sousa, FC; Souza, CM; Vasconcelos, SM; Viana, GS | 1 |
| Abdallah, HM; Abdel-Sattar, EA; Asaad, GF; Mouneir, SM | 1 |
| Bošković, M; Grabnar, I; Kores Plesničar, B; Terzič, T; Vovk, T | 1 |
| Bansal, PK; Bisht, R; Prakash, A; Thakur, KS | 1 |
| Bouvier, ML; Gaebel, W; Henning, U; Schmitt, A; Schneider-Axmann, T; von Wilmsdorff, M | 1 |
| Andreazza, AC; Fletcher, PJ; Lister, J; Navaid, B; Nesarajah, Y; Nobrega, JN; Remington, G; Teo, C; Wilson, AA; Wilson, VS | 1 |
| Haleem, DJ; Samad, N | 1 |
| Dhingra, D; Gahalain, N; Goswami, S | 1 |
| Kehinde, AJ | 1 |
| Bătrînu, MG; Croitoru, MD; Dogaru, MT; Fogarasi, E; Jîtcă, G; Miklos, A; Ősz, BE; Rusz, CM; Tero-Vescan, A; Vari, CE | 1 |
| Górski, KM; Klimczyk, J; Mokros, Ł; Pietras, T; Witusik, A | 1 |
| El-Sayed, NM; Mosaad, SM; Selim, MA | 1 |
1 trial(s) available for haloperidol and malondialdehyde
| Article | Year |
|---|---|
The impact of omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: an open-label pilot study.
Topics: Adolescent; Adult; Akathisia, Drug-Induced; Antioxidants; Antipsychotic Agents; Ascorbic Acid; Erythrocytes; Fatty Acids, Omega-3; Female; Haloperidol; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Pilot Projects; Schizophrenia; Schizophrenic Psychology; Superoxide Dismutase; Treatment Outcome; Vitamin E | 2007 |
24 other study(ies) available for haloperidol and malondialdehyde
| Article | Year |
|---|---|
Oxidative stress induced by administration of the neuroleptic drug haloperidol is attenuated by higher doses of haloperidol.
Topics: Animals; Cerebral Cortex; Corpus Striatum; Disulfides; Fluorescent Dyes; Glutathione; Haloperidol; Homeostasis; Lipid Peroxidation; Malondialdehyde; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Stress, Physiological | 1992 |
Depletion of glutathione and enhanced lipid peroxidation in the CSF of acute psychotics following haloperidol administration.
Topics: Administration, Oral; Adolescent; Adult; Female; Glutathione; Haloperidol; Humans; Lipid Peroxidation; Male; Malondialdehyde; Psychiatric Status Rating Scales; Psychotic Disorders | 1994 |
Oxidative stress and thiol modification induced by chronic administration of haloperidol.
Topics: Animals; Brain; Glutathione; Haloperidol; Homeostasis; Malondialdehyde; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds | 1993 |
Reversal of haloperidol-induced orofacial dyskinesia by quercetin, a bioflavonoid.
Topics: Animals; Antipsychotic Agents; Brain; Catalase; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Glutathione; Haloperidol; Male; Malondialdehyde; Quercetin; Rats; Rats, Wistar; Superoxide Dismutase | 2003 |
Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia.
Topics: Animals; Antipsychotic Agents; Catalase; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Glutathione; Haloperidol; Male; Malondialdehyde; Prosencephalon; Quercetin; Rats; Rats, Wistar; Superoxide Dismutase | 2003 |
Protective effects of N-n-butyl haloperidol iodide on myocardial ischemia-reperfusion injury in rabbits.
Topics: Animals; Coronary Vessels; Dose-Response Relationship, Drug; Haloperidol; Hemodynamics; Malondialdehyde; Myocardial Reperfusion Injury; Myocardium; Rabbits | 2004 |
Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia: a biochemical and neurochemical study.
Topics: Animals; Anti-Dyskinesia Agents; Antioxidants; Antipsychotic Agents; Catalase; Chlorpromazine; Diazepam; Dyskinesia, Drug-Induced; Enzyme-Linked Immunosorbent Assay; Female; Haloperidol; Hypnotics and Sedatives; Lipid Peroxidation; Male; Malondialdehyde; Neostriatum; Neuroprotective Agents; Neurotransmitter Agents; Nitric Oxide; Pyridines; Rats; Rats, Wistar; Superoxide Dismutase; Zolpidem | 2007 |
The protective effects of N-n-butyl haloperidol iodide on myocardial ischemia-reperfusion injury in rats by inhibiting Egr-1 overexpression.
Topics: Animals; Base Sequence; Cells, Cultured; Early Growth Response Protein 1; Gene Expression Regulation; Haloperidol; Male; Malondialdehyde; Molecular Structure; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oligodeoxyribonucleotides; Peroxidase; Rats; Rats, Sprague-Dawley; RNA, Messenger; Troponin I; Tumor Necrosis Factor-alpha | 2007 |
Neuroprotective effect of naphtha[1,2-d]thiazol-2-amine in an animal model of Parkinson's disease.
Topics: Animals; Antioxidants; Brain; Catalepsy; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione; Glutathione Peroxidase; Haloperidol; Male; Malondialdehyde; Mice; Naphthalenes; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Superoxide Dismutase; Thiazoles | 2009 |
Synthesis of some urea and thiourea derivatives of 3-phenyl/ethyl-2-thioxo-2,3-dihydrothiazolo[4,5-d]pyrimidine and their antagonistic effects on haloperidol-induced catalepsy and oxidative stress in mice.
Topics: Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Brain; Catalepsy; Glutathione; Glutathione Peroxidase; Haloperidol; Male; Malondialdehyde; Mice; Oxidative Stress; Parkinson Disease; Pyrimidines; Superoxide Dismutase; Thiourea; Urea | 2009 |
Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics.
Topics: Adult; Antioxidants; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Glutathione Peroxidase; Haloperidol; Humans; Lipid Peroxidation; Malondialdehyde; Middle Aged; Olanzapine; Oxidative Stress; Quetiapine Fumarate; Risperidone; Schizophrenia; Superoxide Dismutase | 2010 |
N-n-butyl haloperidol iodide protects cardiac microvascular endothelial cells from hypoxia/reoxygenation injury by down-regulating Egr-1 expression.
Topics: Animals; Blood Platelets; Cell Adhesion; Cell Hypoxia; Cell Survival; Cells, Cultured; Down-Regulation; Early Growth Response Protein 1; Endothelial Cells; Endothelium, Vascular; Female; Haloperidol; Intercellular Adhesion Molecule-1; L-Lactate Dehydrogenase; Male; Malondialdehyde; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Oligodeoxyribonucleotides, Antisense; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2010 |
B vitamins attenuate haloperidol-induced orofacial dyskinesia in rats: possible involvement of antioxidant mechanisms.
Topics: Animals; Antioxidants; Antipsychotic Agents; Behavior, Animal; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Glutathione; Haloperidol; Lipid Peroxidation; Male; Malondialdehyde; Movement Disorders; Oxidative Stress; Psychotic Disorders; Rats; Rats, Wistar; Superoxide Dismutase; Vitamin B Complex | 2011 |
Protective effect of Calligonum comosum on haloperidol-induced oxidative stress in rat.
Topics: Animals; Antioxidants; Brain; Flavonoids; Glutathione; Haloperidol; Liver; Male; Malondialdehyde; Oxidative Stress; Phenols; Phytochemicals; Plant Extracts; Polygonaceae; Rats; Superoxide Dismutase | 2014 |
Oxidative stress in schizophrenia patients treated with long-acting haloperidol decanoate.
Topics: Adult; Antioxidants; Antipsychotic Agents; Basal Ganglia Diseases; Catalase; Female; Glutathione; Glutathione Peroxidase; Haloperidol; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Psychopathology; Schizophrenia; Severity of Illness Index; Superoxide Dismutase | 2013 |
Beneficial effect of candesartan and lisinopril against haloperidol-induced tardive dyskinesia in rat.
Topics: Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Body Weight; Grooming; Haloperidol; Hand Strength; Interleukin-1beta; Lisinopril; Male; Malondialdehyde; Mastication; Maze Learning; Memory; Motor Activity; Movement Disorders; Nitrites; Oxidative Stress; Rats, Wistar; Rotarod Performance Test; Stereotyped Behavior; Tetrazoles; Tumor Necrosis Factor-alpha | 2015 |
Sex-dependent metabolic alterations of rat liver after 12-week exposition to haloperidol or clozapine.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Biomarkers; Cholesterol, HDL; Clozapine; Female; Glucose; Glycogen; Haloperidol; Liver; Male; Malondialdehyde; Organ Size; Oxidative Stress; Rats, Sprague-Dawley; Sex Characteristics; Sterol Regulatory Element Binding Proteins; Triglycerides | 2014 |
Lipoic acid and haloperidol-induced vacuous chewing movements: Implications for prophylactic antioxidant use in tardive dyskinesia.
Topics: Aldehydes; Analysis of Variance; Animals; Antioxidants; Antipsychotic Agents; Haloperidol; Male; Malondialdehyde; Mastication; Rats; Rats, Sprague-Dawley; Tardive Dyskinesia; Thiobarbituric Acid Reactive Substances; Thioctic Acid | 2017 |
Antioxidant effects of rice bran oil mitigate repeated haloperidol-induced tardive dyskinesia in male rats.
Topics: Animals; Antioxidants; Behavior, Animal; Catalase; Corpus Striatum; Disease Models, Animal; Glutathione Peroxidase; Haloperidol; Lipid Peroxidation; Male; Malondialdehyde; Motor Activity; Oxidative Stress; Rats; Rats, Wistar; Rice Bran Oil; Superoxide Dismutase; Tardive Dyskinesia | 2017 |
Protective effect of hesperetin against haloperidol-induced orofacial dyskinesia and catalepsy in rats.
Topics: Animals; Behavior, Animal; Brain; Catalepsy; Dopamine; Dyskinesia, Drug-Induced; Dyskinesias; Glutathione; Haloperidol; Hesperidin; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Serotonin; Superoxide Dismutase | 2018 |
Functional Oil from Black Seed Differentially Inhibits Aldose-reductase and Ectonucleotidase Activities by Up-regulating Cellular Energy in Haloperidol-induced Hepatic Toxicity in Rat Liver.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Aldehyde Reductase; Animals; Chemical and Drug Induced Liver Injury; Energy Metabolism; GPI-Linked Proteins; Haloperidol; Liver; Male; Malondialdehyde; Phytochemicals; Plant Oils; Rats, Wistar; Seeds; Sorbitol; Up-Regulation | 2017 |
A Simple HPLC/DAD Method Validation for the Quantification of Malondialdehyde in Rodent's Brain.
Topics: Acetonitriles; Animals; Brain; Chromatography, High Pressure Liquid; Haloperidol; Humans; Malondialdehyde; Metformin; Rats | 2021 |
Effect of haloperidol and amisulpride on the production of malondialdehyde in reaction to free radical attack on deoxyrybosis.
Topics: Amisulpride; Free Radicals; Haloperidol; Humans; Hydrogen Peroxide; Malondialdehyde | 2021 |
Lycopene protects against Bisphenol A induced toxicity on the submandibular salivary glands via the upregulation of PPAR-γ and modulation of Wnt/β-catenin signaling.
Topics: Animals; Antioxidants; beta Catenin; Carotenoids; Epoxy Resins; Glutathione; Keratin-5; Lycopene; Malondialdehyde; PPAR gamma; Protective Agents; Rats; Salivary Glands; Tumor Necrosis Factor-alpha; Up-Regulation; Water | 2022 |